Risk factors and pathogenic significance of bacteremic pneumonia in adult patients with community-acquired pneumococcal pneumonia

Journal of Infection

Volumn 66, Issue 1, 2013, Pages 34-40

  Kang, Cheol In ^a   Song, Jae Hoon ^a,b   Kim, So Hyun ^b   Chung, Doo Ryeon ^a   Peck, Kyong Ran ^a   Thamlikitkul, Visanu ^c   Wang, Hui ^d,k   So, Thomas Man Kit ^e,l   Hsueh, Po Ren ^f   Yasin, Rohani Md ^g   Carlos, Celia C ^h   Van, Pham Hung ⁱ   Perera, Jennifer ^j  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

^c MAHIDOL UNIVERSITY   (Thailand)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^e PRINCESS MARGARET HOSPITAL   (Hong Kong)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^g INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

^h RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

ⁱ UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

^j UNIVERSITY OF COLOMBO   (Sri Lanka)

^k PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^l SureCare Medical Centre   (Hong Kong)

more..

Author keywords

Bacteremia; Community acquired pneumonia; Risk factors; Streptococcus pneumoniae; Treatment outcome

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; AGE; AGED; ARTICLE; BACTEREMIA; BACTERIAL PNEUMONIA; CEREBROVASCULAR DISEASE; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; RISK FACTOR; SEPTIC SHOCK; SMOKING; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE;

AGED; ASIA; BACTEREMIA; CHI-SQUARE DISTRIBUTION; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PNEUMONIA, PNEUMOCOCCAL; PROSPECTIVE STUDIES; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE;

EID: 84870729932     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2012.08.011     Document Type: Article

References (24)

1. Musher D.M., Alexandraki I., Graviss E.A., Yanbeiy N., Eid A., Inderias L.A., et al. Bacteremic and nonbacteremic pneumococcal pneumonia. A prospective study. Medicine (Baltimore) 2000, 79:210-221.
2. Jover F., Cuadrado J.M., Andreu L., Martinez S., Canizares R., de la Tabla V.O., et al. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia. Eur J Intern Med 2008, 19:15-21.
3. Kumashi P., Girgawy E., Tarrand J.J., Rolston K.V., Raad I.I., Safdar A. Streptococcus pneumoniae bacteremia in patients with cancer: disease characteristics and outcomes in the era of escalating drug resistance (1998-2002). Medicine (Baltimore) 2005, 84:303-312.
4. Garnacho-Montero J., Garcia-Cabrera E., Diaz-Martin A., Lepe-Jimenez J.A., Iraurgi-Arcarazo P., Jimenez-Alvarez R., et al. Determinants of outcome in patients with bacteraemic pneumococcal pneumonia: importance of early adequate treatment. Scand J Infect Dis 2010, 42:185-192.
5. Agbaht K., Diaz E., Munoz E., Lisboa T., Gomez F., Depuydt P.O., et al. Bacteremia in patients with ventilator-associated pneumonia is associated with increased mortality: a study comparing bacteremic vs. nonbacteremic ventilator-associated pneumonia. Crit Care Med 2007, 35:2064-2070.
6. Cho J.H., Park K.H., Kim S.H., Bang J.H., Park W.B., Kim H.B., et al. Bacteremia is a prognostic factor for poor outcome in spontaneous bacterial peritonitis. Scand J Infect Dis 2007, 39:697-702.
7. Liu J.W., Hsu Y.M., Huang Y.F. Independent prognostic factors for fatality in patients with urinary tract infection caused by Serratia marcescens. Infect Control Hosp Epidemiol 2004, 25:80-82.
8. Laupland K.B., Church D.L., Mucenski M., Sutherland L.R., Davies H.D. Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis 2003, 187:1452-1459.
9. Perello R., Miro O., Marcos M.A., Almela M., Bragulat E., Sanchez M., et al. Predicting bacteremic pneumonia in HIV-1-infected patients consulting the ED. Am J Emerg Med 2010, 28:454-459.
10. Bordon J., Peyrani P., Brock G.N., Blasi F., Rello J., File T., et al. The presence of pneumococcal bacteremia does not influence clinical outcomes in patients with community-acquired pneumonia: results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort study. Chest 2008, 133:618-624.
11. Berjohn C.M., Fishman N.O., Joffe M.M., Edelstein P.H., Metlay J.P. Treatment and outcomes for patients with bacteremic pneumococcal pneumonia. Medicine (Baltimore) 2008, 87:160-166.
12. Kim S.H., Song J.H., Chung D.R., Thamlikitkul V., Yang Y., Wang H., et al. Changing trends in antimicrobial resistance and serotypes of Streptococcus pneumoniae isolates in Asian countries: an Asian Network for Surveillance of Resistant Pathogens (ANSORP) study. Antimicrob Agents Chemother 2012, 56:1418-1426.
13. Song J.H., Oh W.S., Kang C.I., Chung D.R., Peck K.R., Ko K.S., et al. Epidemiology and clinical outcomes of community-acquired pneumonia in adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. Int J Antimicrob Agents 2008, 31:107-114.
14. Friedman N.D., Kaye K.S., Stout J.E., McGarry S.A., Trivette S.L., Briggs J.P., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791-797.
15. Falguera M., Trujillano J., Caro S., Menendez R., Carratala J., Ruiz-Gonzalez A., et al. A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia. Clin Infect Dis 2009, 49:409-416.
16. Lauderdale T.L., Wagener M.M., Lin H.M., Huang I.F., Lee W.Y., Hseih K.S., et al. Serotype and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from Taiwanese children: comparison of nasopharyngeal and clinical isolates. Diagn Microbiol Infect Dis 2006, 56:421-426.
17. Song J.H., Jung S.I., Ko K.S., Kim N.Y., Son J.S., Chang H.H., et al. High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an ANSORP study). Antimicrob Agents Chemother 2004, 48:2101-2107.
18. Weinberger D.M., Harboe Z.B., Sanders E.A., Ndiritu M., Klugman K.P., Ruckinger S., et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010, 51:692-699.
19. Marrie T.J., Low D.E., De Carolis E. A comparison of bacteremic pneumococcal pneumonia with nonbacteremic community-acquired pneumonia of any etiology-results from a Canadian multicentre study. Can Respir J 2003, 10:368-374.
20. Musher D.M., Rueda-Jaimes A.M., Graviss E.A., Rodriguez-Barradas M.C. Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia. Clin Infect Dis 2006, 43:1004-1008.
21. Nuorti J.P., Butler J.C., Farley M.M., Harrison L.H., McGeer A., Kolczak M.S., et al. Cigarette smoking and invasive pneumococcal disease. Active bacterial core surveillance team. N Engl J Med 2000, 342:681-689.
22. Austrian R., Gold J. Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. Ann Intern Med 1964, 60:759-776.
23. Flory J.H., Joffe M., Fishman N.O., Edelstein P.H., Metlay J.P. Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults. Epidemiol Infect 2009, 137:717-726.
24. Metersky M.L., Ma A., Bratzler D.W., Houck P.M. Predicting bacteremia in patients with community-acquired pneumonia. Am J Respir Crit Care Med 2004, 169:342-347.